Blbk Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Delhi, Delhi, India, established in 2001.
2001 Delhi, Delhi, India Active
Last Updated:
Access Report
About Blbk Pharmaceuticals Private Limited

Blbk Pharmaceuticals Private Limited, a active private limited company, was established on 28 February 2001 in Delhi, Delhi, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U74899DL2001PTC109844. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.92 M.

Formerly known as Nitika Ayurvedics Private Limited. It upholds a compliant status. Its leadership includes Vimal Kishore Kandwal (Director), Shelandra Kumar (Director), Atul Kumar Singh (Director). Past directors included Usman Rajput, Atul Kumar Singh, Naresh Sachdeva. It holds ₹1.35 Cr open charges and ₹1.96 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ad-4C Pitampura, Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL2001PTC109844

  • Registration Number

    109844

  • Incorporation Date

    28 February 2001

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹1.92 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.92 M
  • Company Age 24 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.35 Cr
  • Satisfied Charges ₹ 1.96 Cr
  • Revenue Growth **** -3.48%
  • Profit Growth **** 42.03%
  • Ebitda **** -156.07%
  • Net Worth 61699.33%
  • Total Assets **** 11.83%
Company report

Blbk Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Blbk Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Blbk Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vimal Kishore Kandwal Director 07 Aug 2025 Current
Shelandra Kumar Director 30 Dec 2017 Current
Atul Kumar Singh Director 24 Feb 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Jun 2019 Past
Pramod Abcsdd Director 08 Aug 2025 Past
Pramod Abcsdd Director 22 Feb 2020 Past
Pramod Abcsdd Director 15 Apr 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Blbk Pharmaceuticals.

Blbk Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.48% decrease. The company also saw a substantial improvement in profitability, with a 42.03% increase in profit. The company's net worth Soared by an impressive increase of 61699.33%.

Blbk Pharmaceuticals revenue growth over time
Blbk Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -3.48%
*******
*******
*******
*******
Revenue from Operations
*******
 -3.46%
*******
*******
*******
*******
Total Assets
*******
 11.83%
*******
*******
*******
*******
Profit or Loss
*******
 42.03%
*******
*******
*******
*******
Net Worth
*******
 61699.33%
*******
*******
*******
*******
EBITDA
*******
 -156.07%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Blbk Pharmaceuticals?

In 2023, Blbk Pharmaceuticals had a public holding of 77.60%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹13,479,748.00

Satisfied Charges

₹19,640,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.69 Cr
  • Uco Bank : 0.66 Cr
Latest Charge Details
Date Lender Amount Status
28 Jul 2025 Others ₹6.91 M Open
24 Mar 2022 Uco Bank ₹0.57 M Open
26 Jun 2020 Uco Bank ₹6.00 M Open
25 May 2006 State Bank Of India ₹0.72 M Satisfied
25 May 2006 State Bank Of India ₹0.72 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Blbk Pharmaceuticals?

Unlock and access historical data on people associated with Blbk Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Blbk Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blbk Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Blbk Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Blbk Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    Progress on Vimal Kishore Kandwal was appointed as a Director was appointed as a Director on 07 Aug 2025 & has been associated with this company since 6 months 5 days . was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 6.91 M with Charge ID 101129723 was registered on 28 Jul 2025. was completed.

  • Balance Sheet

    Progress on Blbk Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    The activity A charge with Uco Bank of Rs. 6.00 M registered on 26 Jun 2020 with Charge ID 100354991 was modified on 30 Sep 2023. was completed.

  • Charges

    A charge with Uco Bank amounted to Rs. 0.57 M with Charge ID 100586275 was registered on 24 Mar 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Blbk Pharmaceuticals Private Limited?

The CIN of Blbk Pharmaceuticals Private Limited is U74899DL2001PTC109844.

Where is Blbk Pharmaceuticals Private Limited headquartered?

Blbk Pharmaceuticals Private Limited is headquartered at Ad-4C Pitampura, Delhi, Delhi, 110034.

When was Blbk Pharmaceuticals Private Limited incorporated?

Blbk Pharmaceuticals Private Limited was incorporated on 28 February 2001.

Who are the current directors of Blbk Pharmaceuticals Private Limited?

The current directors of Blbk Pharmaceuticals Private Limited are

What is the primary industry of Blbk Pharmaceuticals Private Limited?

The primary industry of Blbk Pharmaceuticals Private Limited is Manufacturing.

Is Blbk Pharmaceuticals Private Limited a listed company?

Blbk Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Blbk Pharmaceuticals Private Limited?

The authorized capital of Blbk Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹1.92 M.

What is the compliance status of Blbk Pharmaceuticals Private Limited?

The compliance status of Blbk Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available